Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000125

Director sold 25,000 shares at $25.96 ($648,888)

  • Director acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Foster-Cheek Kaye I · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-09 Exercise or conversion : show line 1 in the form +25,000 $18.09 $452,250 36,524 D
2023-08-09 Sale : show line 2 in the form −25,000 $25.96 $648,888 11,524 D
Open-market sales · 25,000 sh · avg $25.96 · $648,888

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-08-09 Exercise or conversion : show line 3 in the form Stock options (right to buy) −25,000 4,307 D
Loading xslF345X05/wk-form4_1691784273.xml…